GlaxoSmithKline agrees to pay US$150 million to settle drug price fraud case

WASHINGTON (AP) - GlaxoSmithKline PLC will pay $150 million US to settle claims it overcharged the U.S. government for two anti-nausea drugs, and prosecutors say they're looking into 150 cases of drug price fraud....More